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The cocaine- and amphetamine-regulated transcript (CART ) has been the subject of
significant interest for over a decade. Work to decipher the detailed mechanism of CART
function has been hampered by the lack of specific pharmacological tools like antagonists
and the absence of a specific CART receptor(s). However, extensive research has been
devoted to elucidate the role of the CART peptide and it is now evident that CART is a key
neurotransmitter and hormone involved in the regulation of diverse biological processes,
including food intake, maintenance of body weight, reward and addiction, stress response,
psychostimulant effects and endocrine functions (Rogge et al., 2008; Subhedar et al.,
2014). In this review, we focus on knowledge gained on CART’s role in controlling appetite
and energy homeostasis, and also address certain species differences between rodents
and humans.
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INTRODUCTION
Experiments conducted with acute administration of cocaine or
amphetamine in rodents resulted in the upregulation of a par-
ticular mRNA species in the striatum of the brain that was
subsequently named “cocaine- and amphetamine-regulated tran-
script” (CART) and the encoded peptides are referred to as CART
peptides (Spiess et al., 1981; Douglass et al., 1995). Importantly,
CART mRNA levels were also found increased in the nucleus
accumbens on post-mortem tissues from human victims of
cocaine overdose (Albertson et al., 2004). CART is transcribed
as two alternatively spliced mRNAs that are of different lengths
and hence produce pro-peptides of different lengths, called pro-
CART 1–89 and proCART 1–102 (Douglass et al., 1995; Douglass
and Daoud, 1996). However, the mRNA splicing has no effect
on the final peptide, as the active parts of the CART peptides
are encoded by a sequence that lies downstream of the spliced
region and is therefore identical in both pro-peptides (Douglass
et al., 1995; Dey et al., 2003). However, the proCART peptides
contain several cleavage sites that allow post-translational pro-
cessing by pro-hormone convertases in a tissue-specific manner
(Seidah et al., 1991; Douglass et al., 1995; Douglass and Daoud,
1996; Dong et al., 1997; Koylu et al., 1997; Steiner, 1998; Kuhar
and Yoho, 1999; Thim et al., 1999; Vrang et al., 1999a; Dun et al.,
2000; Dey et al., 2003; Stein et al., 2006). This processing produces
at least two known biologically active peptides, CART I (55–102)
and CART II (62–102), each containing three potential disulphide
bridges (Douglass et al., 1995; Thim et al., 1998; Dey et al., 2003;
Dominguez, 2006).
CART peptides are evolutionarily strongly conserved between
rodent and human (Douglass et al., 1995; Douglass and Daoud,
1996; Adams et al., 1999), with about 95% amino-acid iden-
tity between the active neuropeptides (Douglass and Daoud,
1996; Thim et al., 1998; Yermolaieva et al., 2001; Dominguez,
2006), suggestive of a conserved critical physiological function.
Notably, high levels of CART expression have been identified
to localize in brain regions that include the arcuate nucleus
(Arc), the lateral hypothalamus area (LHA), the paraventricu-
lar nucleus (PVN), and the nucleus accumbens (Acb) (Douglass
et al., 1995; Gautvik et al., 1996; Couceyro et al., 1997; Koylu
et al., 1997, 1998; Kristensen et al., 1998; Vrang et al., 1999a;
Hubert and Kuhar, 2008; Cavalcante et al., 2011), suggesting an
important role for CART in the regulation of food intake and
energy homeostasis. This is consistent with results from injec-
tions of CART peptide into the nucleus accumbens which have
shown an inhibition of feeding in rodents (Yang and Shieh, 2005;
Jean et al., 2007). In addition, CART in the Arc is co-localized
with α-melanocyte stimulating hormone (α-MSH) (Chronwall,
1985; Adam et al., 2002), which is produced from the proop-
iomelanocortin (POMC) precursor and is a major inhibitor of
appetite and food intake (Fan et al., 1997; Kim et al., 2000; Zheng
et al., 2005). In the Arc, CART mRNA levels are regulated by
circulating leptin (Kristensen et al., 1998; Schwartz et al., 2000)
and are increased by peripheral leptin administration (Elias et al.,
1998; Kristensen et al., 1998; Wang et al., 1999; Elias et al., 2001),
again indicative of a critical role in energy balance regulation.
Moreover, injection of CART I (55–102) into the PVN or Arc
of rats markedly enhanced the mRNA expression for the uncou-
pling protein-1 (UCP-1) in brown adipose tissue, relating CART
peptides not only to the control of feeding but also the modula-
tion of energy expenditure (Wang et al., 2000; Kong et al., 2003).
Mechanistically, it has been shown that application of CART I
(55–102) to hypothalamic explants can stimulate the release of
corticotropin-releasing hormone (CRH) and thyrotropin releas-
ing hormone, which further links CART to the regulation of
the hypothalamic-pituitary-adrenal axis (Stanley et al., 2001).
Importantly, several genetic studies have associated mutations or
polymorphisms in the CART gene in humans with obesity, clearly
demonstrating a crucial role of CART in the control of energy
homeostasis also in humans (Hager et al., 1998; Challis et al.,
2000; del Giudice et al., 2001; Yamada et al., 2002; Dominguez
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et al., 2004a; Guerardel et al., 2005; Yanik et al., 2006; Rigoli et al.,
2010).
While a specific CART receptor(s) has not been identified
to date, there is strong evidence that CART signaling can be
blocked by pertussis toxin (PTX), indicative of the involvement
of an inhibitory G-protein-coupling receptor that couples to
Gi/o proteins (Yermolaieva et al., 2001; Lakatos et al., 2005; Sen
et al., 2007). For example, CART I (55–102) has been described
to inhibit voltage-gated L-type Ca2+ channels in hippocampal
neurons, an effect that was blocked by treatment with PTX
(Yermolaieva et al., 2001). Furthermore, central administration of
CART I (55–102) stimulated the phosphorylation of cyclic AMP-
response-element-binding protein (CREB) in CRH neurons in
the PVN of fasted and fed rats (Sarkar et al., 2004), which again
is classified as a PTX-sensitive mechanism. Finally, CART I (55–
102) application activated extracellular signal-regulated kinase
(ERK) phosphorylation in the rodent pituitary-derived cell lines,
AtT20 and GH3, and such CART-induced effects were attenu-
ated by a MEK kinase inhibitor as well as pre-treatment with PTX
(Lakatos et al., 2005), further supporting the mediation of CART
action by inhibitory G proteins.
DISTRIBUTION OF CART EXPRESSION
CART can be found in both the central nervous system (CNS)
(Spiess et al., 1981; Douglass et al., 1995; Gautvik et al., 1996;
Couceyro et al., 1997; Koylu et al., 1997; Smith et al., 1999;
Hubert and Kuhar, 2005, 2008; Dominguez, 2006; Vrang, 2006)
and the periphery (Koylu et al., 1997; Broberger et al., 1999;
Ekblad et al., 2003; Larsen et al., 2003;Wierup et al., 2004; Ekblad,
2006; Vicentic, 2006; de Lartigue et al., 2007; Kasacka et al., 2012).
CART mRNA-containing neurons are present in high densities
in diverse regions such as the Edinger-Westphal nucleus, gan-
glion cells in the retina, mitral and tufted cells of the olfactory
bulb, sensory barrels in the cerebral cortex, the pituitary, lam-
ina X of the spinal cord, medulla of the adrenal cortex, the vagal
nuclei, and a number of hypothalamic nuclei (Douglass et al.,
1995; Couceyro et al., 1997). Expression of CART in periph-
eral blood and pituitary portal has also led to the identification
of CART-positive neuroendocrine neurons in the hypothalamus,
where CART was demonstrated to constitute a releasing fac-
tor delivered to the hypothalamic-pituitary-adrenal (HPA) portal
circuit for potential endocrine regulation (Larsen et al., 2003;
Vicentic, 2006). Consistent with a role in energy homeostasis,
CART expression has also been associated with glucose-sensing
sites both centrally and peripherally, in both rodents and humans
(Jensen et al., 1999; Wierup et al., 2005, 2006, 2007; Kasacka et al.,
2012). In the periphery, CART expression has been identified in
the islet endocrine cells, ganglionic cells, as well as the sensory
and autonomic nerve fibers of the pancreas (Jensen et al., 1999;
Wierup et al., 2006, 2007; Kasacka et al., 2012). A recent paper also
reported the expression of CART mRNA and protein in subcuta-
neous and visceral white adipose tissues from both rat and human
(Banke et al., 2013), serving a potential novel role in adipocytes
by fine-tuning lipolysis and lipase activation to affect lipid- and
glucose-homeostasis (Vasseur et al., 2007; Banke et al., 2013).
In addition to the structural conservancy between CART
isoforms across species (Douglass et al., 1995; Douglass and
Daoud, 1996; Adams et al., 1999; Dey et al., 2003), functional
conservation of CART in the mammalian neuroendocrine sys-
tem has also been implicated in the resembling CART mRNA
and peptide distribution pattern in the brain observed between
humans, rodents, as well as monkeys (Douglass and Daoud,
1996; Gautvik et al., 1996; Charnay et al., 1999; Cavalcante
et al., 2011). As a leptin-regulated neurotransmitter with potent
appetite-suppressing activity (Kristensen et al., 1998), CART
expression in the CNS is highly localized to distinct brain areas
critically involved in the control of energy homeostasis, lim-
bic and sensory functions, as well as throughout the HPA axis
(Douglass et al., 1995; Gautvik et al., 1996; Koylu et al., 1997;
Charnay et al., 1999; Dominguez, 2006; Hubert and Kuhar, 2008;
Cavalcante et al., 2011). Localization analyses of CART expression
at the mRNA and peptide levels have demonstrated concordance
across studies applying cDNA sequencing (Douglass et al., 1995),
in situ hybridization (Douglass et al., 1995; Couceyro et al., 1997)
and immunohistochemistry (Koylu et al., 1997). Indeed, CART
mRNA has been shown to constitute the third most abundant
transcript identified in rat hypothalamus after subtraction of
cerebellar and hippocampal mRNAs (Gautvik et al., 1996).
CENTRAL CART IN THE REGULATION OF APPETITE AND
ENERGY HOMEOSTASIS
A considerable amount of information has been accumulated
for the role of CART in modulating metabolism via actions
within the CNS. Together with several other critical neuropep-
tides, CART is integrated into the circuits that control the overall
regulation of energy balance. The major site of action is the
hypothalamic arcuate nucleus located at the base of the hypotha-
lamus in an area where the blood-brain barrier is semi-permeable,
hence uniquely assessable to circulating humoral and metabolic
mediators (Barsh and Schwartz, 2002; Berthoud, 2002; Faouzi
et al., 2007). As a consequence, the arcuate nucleus circuit serves
as sensor of whole-body energy status represented by adiposity
levels and promptly directs downstream responses accordingly
through neuronal signaling to maintain a constant level of fuel
stores (Schwartz et al., 2000; Barsh and Schwartz, 2002).
Two sets of neurons with reciprocal metabolic effects reside
in the Arc, namely the orexigenic neuropeptide Y (NPY)/AgRP
neurons which promote food intake and reduce energy expendi-
ture, and the adjacent anorexigenic POMC/CART neurons that
inhibit food intake and increase energy expenditure (Chronwall,
1985; Elmquist et al., 1998; Barsh and Schwartz, 2002). In
response to circulating hormones, such as leptin and insulin
that are secreted from adipose tissues and the pancreas, respec-
tively, with a plasma level proportionate to body adipose stores
(Zhang et al., 1994; McGregor et al., 1996; Ostlund et al., 1996),
hypothalamic expression of the two sets of neurons is differen-
tially regulated (Schwartz et al., 2000). For instance, leptin and
insulin levels are reduced following food deprivation that low-
ers body fat stores, which inhibits POMC/CART neurons and
stimulates NPY/AgRP neurons (Schwartz et al., 2000). In addi-
tion, the NPY/AgRP neurons are also subject to activation by the
circulating orexigenic peptide ghrelin released from the stom-
ach with peak levels before meal initiation (Nakazato et al.,
2001).
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NPY/AGRP and POMC/CART neurons are not merely two
independent sensors mediating opposing effects and projecting
parallel extensions to second-order hypothalamic neuropeptide
neurons, activity of the two pairs of neurons is subject to regu-
lation by a multitude of mechanisms involved in the control of
energy homeostasis. For instance, neuroanatomical studies have
shown that there are intra-arcuate connections between the two
neuronal subgroups, which are autoregulated by melanocortin
peptides as well as local γ-aminobutyric acid (GABA)-mediated
effects (Bagnol et al., 1999; Cowley et al., 2001). POMC/CART
neurons express the melanocortin 3-receptor (MC3-R) which
is specific for melanocortin peptides derived from the post-
translational cleavage of POMC (Bagnol et al., 1999), such as
the anorectic α-MSH (Fan et al., 1997; Huszar, 1997; Kim et al.,
2000; Zheng et al., 2005). The activation of a subset of Arc
POMC/CART neurons following exposure to leptin via leptin
receptors has been reported to impose an autoinhibitory effect
exerted through MC3-R activation in response to elevated release
of POMC-derived peptides (Elias et al., 1998; Ahima et al., 1999;
Cowley et al., 2001). However, inconsistency exists with the pro-
posed negative autoreceptor manner of MC3-R in diminishing
POMC/CART neuronal activity due to the mild increase in adi-
posity and body weight observed inMC3-R-deficientmice (Butler
et al., 2000; Chen et al., 2000). In addition to the potential
feedback mechanism described above, the inhibitory neurotrans-
mitter GABA constitutes a principal modulator in the complex
intra-arcuate circuit (Cowley et al., 2001). Subpopulations of
Arc neurons harbor colocalized expression of NPY and GABA
(Horvath et al., 1997), where GABA released from the orexigenic
NPY/GABA terminals induces inhibitory post-synaptic currents
(IPSCs) that consequently hyperpolarizing hence decreasing fir-
ing rate of the post-synaptic POMC/CART neurons (Cowley
et al., 2001). Besides such direct neuronal innervations synaps-
ing into Arc POMC/CART neurons by GABA-secreting NPY
neurons (Cowley et al., 2001), a recent investigation has demon-
strated the direct action of leptin on hyperpolarizing presynap-
tic GABAergic neurons in reducing GABA-mediated inhibitory
tone to POMC/CART cells (Vong et al., 2011), whilst ghrelin
was shown to trigger the opposite events on the same neurons
(Cowley et al., 2003). Collectively, the electrophysiological regu-
lation of arcuate POMC/CART neurons constitutes two primary
mechanisms, including the direct effects of potent neuropep-
tide modulators on membrane potential through influencing
ion channel activity, as well as the indirect impacts on IPSC
frequency marking GABA inhibition from local NPY/GABA neu-
rons (Cowley et al., 2001). The resultant resting action potential
is purported to concurrently involve the autoregulatory effects of
melanocortin peptides (Cowley et al., 2001), ultimately providing
an integrated circuit at the Arc for the regulation of food intake
and energy homeostasis.
Present in both classic neuroendocrine neurons and hypotha-
lamic projection neurons, Arc CART displays an almost 100%
colocalization with POMC and complete segregation from the
more medially located orexigenic NPY in rodents (Elias et al.,
1998; Vrang et al., 1999a; Fekete et al., 2000, 2004). The co-
existence of CART with POMC and derivatives such as α-MSH
were found to persist throughout the rostrocaudal extent of
the Arc (Vrang et al., 1999a), wherein CART immunoreactivity
(IR) was depicted in a separate study to pervade all α-MSH-
IR perikarya and axons (Menyhért et al., 2007), which accords
with the anorectic role widely adopted for POMC/CART neu-
rons. In accordance with established neuronal projections from
Arc (Schwartz et al., 2000), all α-MSH-IR axons in the PVN have
also been shown to contain CART immunoreactivity (Menyhért
et al., 2007).
In addition to co-storage with the POMC and associated
cleavage products which promote negative energy balance (Fan
et al., 1997; Huszar, 1997; Kim et al., 2000; Zheng et al., 2005),
CART exhibits>95% colocalization with the orexigenic melanin-
concentrating hormone (MCH) (Qu et al., 1996; Rossi et al., 1997;
Ludwig et al., 1998) at the LHA and zona incerta (ZI) (Vrang
et al., 1999a; Elias et al., 2001; Menyhért et al., 2007). All MCH-
positive cells showed immunoreactivity for CART in the rostral ZI
and the most medial region of LHA, whilst an increasing number
of non-CART MCH cells were detected in the caudal and lateral
parts of the LHA apart from the CART-containing MCH neu-
rons (Vrang et al., 1999a). In regard to the extensive hypothalamic
colocalization of CART-IR with both anorexigenic and orexigenic
neurotransmitters, namely POMC at the Arc and MCH at the
LHA and ZI respectively, it has been hypothesized that CART
co-stored within POMC-IR neurons, functions to counteract the
effects of MCH in feeding stimulation, on the assumption that
CART and MCHmay be co-released (Shimada et al., 1998; Vrang
et al., 1999a). This is supported by the observation of an elevated
CART tone in the MCH-IR LHA neurons in MCH knockout
mice, which exhibited anorexic tendencies marked by hypopha-
gia and a leaner phenotype (Shimada et al., 1998; Vrang et al.,
1999a). Interestingly, no colocalization was found between CART
and another orexigenic peptide confined to neurons in the LHA,
orexin B (de Lecea et al., 1998; Peyron et al., 1998; Sakurai et al.,
1998; Vrang et al., 1999a), which increases in transcription activ-
ity during fasting to elicit stimulatory effects on feeding (Sakurai
et al., 1998).
Colocalization experiments exploring the resemblance of
CART distribution in feeding-related neuronal groups of the
human hypothalamus revealed that, while overlap is seen in cer-
tain areas, some striking differences in colocalization pattern
also exist (Charnay et al., 1999; Elias et al., 2001; Menyhért
et al., 2007). For example, the close overlap of CART and
POMC expression in rodents is not so obvious in the human
brain (Mihaly et al., 2000; Menyhért et al., 2007). In partic-
ular, CART expression could not be detected in the perikarya
and axons of α-MSH-IR neurons but interestingly was found in
approximately 30% of NPY/agouti-related protein (AgRP) neu-
rons (Mihaly et al., 2000) in the human infundibular nucleus
analogous to the Arc in rodents (Menyhért et al., 2007). However,
similar co-expression patterns of CART and other neurotransmit-
ters between human and rodents were seen in the PVN region
(Menyhért et al., 2007). Intriguingly, the co-expression of CART
in NPY/AgRP instead of POMC neurons of the Arc was also
observed in other primates such as monkeys (Grayson et al.,
2006). Comparable with the observation in rodents, CART was
demonstrated to colocalize with MCH in the lateral hypothala-
mus of humans, particularly in the perifornical region where up
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to 50% overlap in immunoreactivities of the two peptides was
detected (Menyhért et al., 2007). In the infundibular nucleus,
fibers comprising MCH-IR were also observed in a portion
of CART-IR axons, suggestive of lateral hypothalamic origin
(Menyhért et al., 2007).
It is of particular interest that CART in humans has been
shown to exhibit the contrasting colocalization with the orex-
igenic NPY/AgRP neurons and complete segregation from
POMC-containing cells in the infundibular nucleus analogous
to the rodent arcuate nucleus, whilst co-storage with MCH
remained in the lateral hypothalamus. Speculations entailing an
orexigenic role of CART as well as the involvement in other func-
tions have therefore arisen, which is supported by the elevated
food intake following CART administration to the PVN even
in rodents (Stanley et al., 2001). Such paradoxical potentials of
CART in feeding behaviors as evident in multiple pharmacologi-
cal and physiological studies will be discussed subsequently in the
present review. With regard to the resembling colocalization with
the orexigenic MCH in the LHA consistent across species inves-
tigated (Ludwig et al., 1998; Vrang et al., 1999a; Elias et al., 2001;
Menyhért et al., 2007), although CART expression appeared unaf-
fected by alterations in energy homeostasis in the MCH neurons
in rodents, MCH administration effectively blocked intracere-
broventricular CART-induced stimulation of central dopamin-
ergic neurons (Yang and Shieh, 2005). Indeed, lateral hypotha-
lamic CART synthesis has been linked to the regulation of
dopaminergic reward pathways (Philpot and Smith, 2006), where
psychostimulant-like effects were modulated by CART through
moderating the activities of dopaminergic neurons (Jaworski
et al., 2003; Dominguez et al., 2004b; Kuhar et al., 2005). Thus,
while possibility exists that CART and MCH may participate
in regulating different physiological functions effectuated by the
same neuronal groups, anatomical and functional interplay of the
two peptides has been indicated to prevail in the interactions
between food intake and reward neurocircuitries (Saper et al.,
2002; Yang and Shieh, 2005; Pang and Han, 2012). Knowledge
regarding the underlying cellular mechanisms awaits further
extension through neuronal mapping and biochemical studies.
While the role of CART in controlling appetite and energy
homeostasis in the human system might be somewhat differ-
ent, in rodents, the neuronal network in which CART is involved
to modulate energy homeostasis has been well-described. The
expression of endogenous CART at brain regions involved in
feeding regulation has been shown to be sensitive to the energy
balance status and the genetic background of mice. In brief, fast-
ing has been documented in various mammals to reduce CART
mRNA levels at the hypothalamic PVN, Arc, perifornical region,
as well as the nucleus accumbens shell (AcbSh) of the stria-
tum, whilst refeeding restored the expression (Kristensen et al.,
1998; Lambert et al., 1998; Adams et al., 1999; Vrang et al.,
1999a, 2000; Henry et al., 2001; Li et al., 2002; Yang and Shieh,
2005; Van Vugt et al., 2006; Germano et al., 2007). As a leptin-
regulated neurotransmitter, the expression of CART mRNA and
peptide levels at the Arc is described to be positively corre-
lated with circulating leptin levels (Kristensen et al., 1998; Ahima
et al., 1999; Ahima and Hileman, 2000; Rohner-Jeanrenaud et al.,
2002; Wortley et al., 2004). This relationship between leptin and
CART levels was less consistently demonstrated at the PVN and
LHA (Wortley et al., 2004), despite evidence supporting a piv-
otal role of CART-containing neurons projecting from the Arc
to the second order neurons located in the PVN and LHA in
producing anorexia (Elias et al., 1999; Wang et al., 2000; Fekete
et al., 2004). Intravenous leptin administration was shown to
induce Fos expression in hypothalamic CART neurons in the
PVN, DMH, Arc, and the ventral premammillary nucleus (Elias
et al., 1998, 2001). Whilst Arc CART mRNA and peptide levels
were strongly downregulated in food-deprived animals, the tran-
scripts were nearly absent in genetically obese fa/fa rats and ob/ob
mice with disrupted leptin signaling, wherein daily intraperi-
toneal leptin treatment led to CART restoration in the Arc and
DMH (Friedman and Halaas, 1998; Kristensen et al., 1998; Ahima
et al., 1999; Ahima and Hileman, 2000; Rohner-Jeanrenaud et al.,
2002), suggesting that leptin-induced anorexigenic actions may
be mediated via CART neurons at the Arc. In comparison, in
the anx/anx anorexia mouse model characterized by marked
reduction in feeding and premature death, CART expression was
significantly lower in the Arc, and less prominently in the DMH
and LHA regions (Johansen et al., 2000). The reduced Arc CART
expression, together with downregulated serum leptin levels, was
attributed to a compensatory response to the energy-deprived
state, as well as a probable molecular defect in the Arc deregu-
lating the cellular source of CART mRNA (Johansen et al., 2000).
In contrast with genetically obese animal models, diet-induced
obese (DIO) rodents subjected to a high fat diet (HFD) have been
shown to display higher Arc CART mRNA levels compared with
lean animals fed a low fat diet, due to hyperleptinaemia (Rohner-
Jeanrenaud et al., 2002; Wortley et al., 2004; Hou et al., 2010).
Elevated CART transcript levels were also found in normal-
weight obesity-prone rats compared to obesity-resistant subjects,
where the Arc leptin-CART pathway was proposed to respond
to fat-rich dietary intervention through inhibiting excessive body
fat accrual by substituting lipid storage with lipid mobilization
(Rohner-Jeanrenaud et al., 2002; Wortley et al., 2004).
Despite purported relevance of CART in the modulation of
gastrointestinal (GI) function, it is at present unclear the definite
roles of enteric CART in intestinal motility, satiety and feeding
behavior (Okumura et al., 2000; Ekblad et al., 2003; Smedh and
Moran, 2003; Tebbe et al., 2004). Convincing evidence supporting
the GI effects of CART have been provided by independent inves-
tigations, where central injections of CART in rodents elicited
an anorexigenic response accompanied by the inhibition of gas-
tric emptying and gastric acid secretion (Okumura et al., 2000;
Asakawa et al., 2001; Smedh and Moran, 2003), while colonic
motility measured by colonic transit time was accelerated (Tebbe
et al., 2004). Contrary to a local ENS effect, such alterations in
GI functions were indicated to be conveyed through CART acting
in the CNS (Okumura et al., 2000; Ekblad et al., 2003; Smedh
and Moran, 2003, 2006; Tebbe et al., 2004), as intraperitoneal
(i.p.) CART administration failed to reduce food consumption
or reproduce similar gastric responses (Okumura et al., 2000;
Tebbe et al., 2004; Skibicka et al., 2009). Furthermore, pretreat-
ment with central injection of CRH receptor antagonist prior to
central CART administration completely abolished the CART-
induced gastric effects, suggesting a central CART-directed CNS
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modulation of the digestive tract behavioral motor functions via
CRH-dependent mechanisms (Okumura et al., 2000; Smedh and
Moran, 2003, 2006; Tebbe et al., 2004).
Consistent with a potential CART pathway connecting
gut-brain signals in the control of food intake, co-expression of
CART and the satiety factor cholescystokinin (CCK)-1 recep-
tors has been detected in the f afferent neurons in rodents
(Crawley et al., 1991; Moran et al., 1992; Mercer and Beart,
1997; Koylu et al., 1998; Broberger et al., 1999; Dun et al.,
2001; Lodge and Lawrence, 2001; Zheng et al., 2002; de Lartigue
et al., 2007). Substantially, the synergistic effect of CART and the
anorexigenic gut hormone CCK (Crawley and Corwin, 1994) on
food intake regulation analogous to that documented for lep-
tin and CCK (Barrachina et al., 1997; Broberger et al., 1999;
Morton et al., 2005; Merino et al., 2008) has been demonstrated
in animal studies, during which the responses to simultane-
ous as well as separate central administration of CART peptide
and the CCK octapeptide (CCK-8) through cannula implan-
tation (Maletinska et al., 2007) were compared (Volkoff, 2006;
Maletinska et al., 2008). In fasted lean mice, the anorexigenic
effect induced by CART delivery was significantly enhanced
by parallel CCK-8 injection when compared with the admin-
istration of each particular peptide alone, while the additive
reaction was also shown in an open field test where locomo-
tor activity of the subjects was inhibited (Maletinska et al.,
2008). On the contrary, application of the CCK-1 receptor
antagonist devazepide blocked CART-induced alteration in food
intake (Maletinska et al., 2008). Such long-lasting coopera-
tive action on feeding was speculated to associate in turn
with the synergistic effect of leptin on CCK-induced satiety,
where CART release from the nodose ganglia was mediated by
the interaction of low-affinity vagal CCK-1 receptors and lep-
tin receptors to produce short-term satiety (Maletinska et al.,
2008; Heldsinger et al., 2012). Furthermore, 17 and 41% of
vagal afferent neurons projecting from the nodose ganglia to
the stomach and duodenum respectively were identified to be
CART-immunoreactive (Zheng et al., 2002). The vagus has been
proposed a mediator of the dorsal hindbrain action of CART
on gastric motor function, as indicated by the inhibitory gas-
tric effects of hindbrain intracerebroventricular (i.c.v.) CART
microinfusion, which was blocked by subdiaphragmatic vago-
tomy (Smedh and Moran, 2003, 2006). In particular, the dorsal
vagal complex (DVC) was demonstrated to be a target site for
both CART and CRH in the suppression of gastric emptying,
where effective inhibition occurred in response to the intra-
parenchymal injection of either peptide into the DVC, at a lower
dose compared to that required to elicit a noticeable inhibitory
effect by hindbrain i.c.v. administration (Smedh and Moran,
2006).
Reciprocal of a central CART-directed modulation of gas-
tric behavior in feeding regulation, the anorectic actions of
central CART have also been proposed to result from stimu-
lation by gut hormones (Hunter et al., 2004). Following food
intake, CCK released in the GI tract has been delineated to
direct CART release from central vagal afferents, where an abun-
dance of CCK-1 receptor mRNA expression was detected in
the nodose ganglion (Broberger et al., 1999; Hunter et al.,
2004). CCK-borne information is then mediated by CART to
the hindbrain sites where suppression of food intake is elicited
(Broberger et al., 1999; Hunter et al., 2004). However, the role
of CART released from vagal afferent terminals in the com-
missural part of the nucleus of the solitary tract (NTS) was
suggested to be minor in mediating vagal satiety signals, as a
diminished suppression of food intake was exerted by direct
NTS subnuclei CART injections compared to hindbrain i.c.v.
CART (Zheng et al., 2001, 2002; Skibicka et al., 2009). Thus,
the potential function of CART on satiation may involve a dis-
tal site of action as well as interaction with other nutritional
transmitters critical for vagally-mediated gastrointestinal sati-
ety (Broberger et al., 1999; Zheng et al., 2002). For instance,
induction of CART immunoreactivity was readily demonstrated
upon CCK administration both in rats and cultured vagal affer-
ent neurons in a state of energy restriction, while refeeding of
starved animals markedly increased CART immunoreactivity via
a CCK-1 receptor antagonist-sensitive mechanism (de Lartigue
et al., 2007, 2010). In addition, introduction of the orexigenic
peptide ghrelin inhibited CCK-mediated CART stimulation (de
Lartigue et al., 2007), illustrating an interplay between gastroin-
testinal orexigenic and anorexic peptides in modulating CART
expression. In particular, immunoreactive CART neurons have
been shown to display differential quantities during developmen-
tal changes in the dorsal motor nucleus of the vagus (DMNV),
wherein vagal preganglionic neurons are responsible for regu-
lating various ingestive behaviors through innervations in the
GI tract (Dun et al., 2001; Zheng et al., 2002). Such descending
expression levels upon maturation indicate a potential signal-
ing role of CART critical in the early post-natal development
(Dun et al., 2001).
PERIPHERAL CART IN THE REGULATION OF ENERGY
HOMEOSTASIS
The proposed physiological role of CART as an endogenous
anorexigenic factor was originally deduced from the inhibition of
food consumption observed in animalmodels following hypotha-
lamic or intracerebroventricular administration of CART-derived
peptides (Kristensen et al., 1998; Vrang et al., 1999b; Larsen
et al., 2000; Volkoff and Peter, 2000; Aja et al., 2001a,b; Stanley
et al., 2001; Nakhate et al., 2011, 2013). Based on the dual
involvement in both hypothalamic modulation of feeding behav-
ior and autonomic control of gastrointestinal functions common
to many neuropeptides, considerable efforts have subsequently
been devoted to the investigation of CART-mediated effects in the
enteric nervous system (ENS) (Couceyro et al., 1998; Kuhar and
Yoho, 1999; Murphy et al., 2000; Okumura et al., 2000; Ekblad
et al., 2003; Ellis and Mawe, 2003; Smedh and Moran, 2003;
Tebbe et al., 2004). Extensive CART expression has been charac-
terized in the ENS of diverse mammals by in situ hybridization
(Ekblad et al., 2003) and immunoassays (Couceyro et al., 1998;
Kuhar and Yoho, 1999; Murphy et al., 2000; Ellis and Mawe,
2003; Kasacka et al., 2012), affirming the presence of CART
mRNA and peptides in nerve cell bodies and fibers innervating
the stomach, small and large intestines of the gastrointestinal tract
(Ekblad, 2006), particularly within the neuroendocrine cells and
myenteric plexus (Kasacka et al., 2012). Such brain-gut CART
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expression suggests that CNS control of feeding and satiety may
be coordinated with local gastric CART-induced effects to pro-
duce an integrated regulation of body weight. This is supported by
the central CART immunoreactivity profile, which depicts con-
centrated expression at the hypothalamic nuclei (Spiess et al.,
1981; Douglass et al., 1995; Gautvik et al., 1996; Couceyro
et al., 1997; Koylu et al., 1997; Smith et al., 1999; Hubert and
Kuhar, 2005, 2008; Dominguez, 2006; Vrang, 2006) constitut-
ing major relays linking the sensory, motor and limbic areas
between forebrain and hindbrain through widespread recipro-
cal networks, orchestrating autonomic, endocrine and behavioral
activities (Fekete et al., 2000; Balkan et al., 2001; Williams et al.,
2001; Tebbe et al., 2004). Specifically, anatomical implications of
CART indicated by enteric CART expression in digestive function
have been further indicated by CART immunoreactivity at the
hypothalamic Arc and PVN neurons, as well as brainstem nuclei
such as NTS and parabrachial nucleus (PBN), both involved in
the efferent and afferent control of GI function through neu-
ropeptidergic mechanisms engaging the complex neuroendocrine
and autonomic pathways (Kristensen et al., 1998; Fekete et al.,
2000; Aja et al., 2001b; Stanley et al., 2001; Zheng et al., 2001;
Tebbe et al., 2003, 2004). In addition, CART expression in the
cholinergic neurons of the myenteric plexus and the pancre-
atic islets further denoted the potential gastric effects of CART
conducted via peripheral receptor targets composing the periph-
eral cholinergic pathways (Couceyro et al., 1998; Jensen et al.,
1999; Ekblad et al., 2003; Tebbe et al., 2004; Wierup et al.,
2004).
The precise functions of CART peptides released by enteric
CART-expressing neurons in the ENS are yet to be determined
(Ekblad, 2006). There has been a lack of direct evidence regarding
a role of locally produced CART in classical neurotransmission
within the GI tract, where intestinal motility as measured by
contractile or relaxatory responses was unaffected by CART pep-
tide application when motor activity studies were performed
in vitro on muscle strips from stomach, small and large intes-
tine (Ekblad et al., 2003). Notably, exceptions to the above may
include specific CART-evoked colonic responses, such as the
attenuation of nitric oxide-induced intestinal relaxation (Ekblad
et al., 2003; Ekblad, 2006), as well as the apparent stimula-
tion of colonic transit, an indirect measure of colonic motor
function (Tebbe et al., 2004). In spite of the confined docu-
mentation of CART involvement in brain-gut interaction and
the indeterminate functional role of enteric CART, accumulat-
ing evidence propose a role of CART in intestinal adaptation,
where the survival and maintenance of enteric neurons is pro-
moted (Ekblad et al., 2003; Ekblad, 2006). Such neuroprotective
property (Ekblad, 2006; Zhang et al., 2012) and intestinal plas-
ticity has been inferred from upregulated CART expression and
increased CART-expressing neurons in atrophic intestine and cul-
tured myenteric neurons respectively, conditions indicative of
neuronal stress or injury (Ekblad et al., 2003; Ekblad, 2006). In
sum, gastric involvement of CART has been evident through dis-
crete histological and physiological experiments, whilst further
detailed characterization of distribution and functions may con-
tribute to a comprehensive understanding of the specific roles of
enteric CART.
FUNCTIONAL IMPLICATIONS OF CART ON ENERGY
METABOLISM FROM PHARMACOLOGICAL INTERVENTIONS
The identification of the underlying mechanisms by which CART
exerts effects on feeding and energy homeostasis have been chal-
lenging due to the lack of any knowledge of the correspond-
ing CART receptor (s) and the absence of specific antagonists.
Nevertheless, numerous studies incorporating both pharmaco-
logical and genetic manipulations of CART expression in murine
models have been endeavored in the last decades to determine
the sites of action and the effects on feeding behavior and
metabolism of the peptide. Overexpression studies to discern
the brain regions mediating CART-induced regulation of feed-
ing have been the most common approach in rodents. Widely
adopted as an appetite-regulating peptide of the CNS with
hypothalamic expression levels modulated by nutritional status
(Kristensen et al., 1998; Thim et al., 1998, 1999; Schwartz et al.,
2000), CART was administrated i.c.v. to address the effects of
overexpression during varying energy states (Kristensen et al.,
1998; Lambert et al., 1998; Thim et al., 1998; Vrang et al., 1999b;
Edwards et al., 2000; Kask et al., 2000; Larsen et al., 2000; Aja et al.,
2001a,b; Bannon et al., 2001; Nakhate et al., 2011, 2013) (Table 1).
The lateral ventricle (LV) of the forebrain or the 3rd ventricle (3V)
have been the major injection targets. I.c.v. injection of recombi-
nant CART peptide has been consistently demonstrated to inhibit
food intake and body weight gain in a dose-dependent manner in
both food-restricted and free-feeding conditions as well as both
under standard chow or a nutritionally complete liquid diet, in
either normal or diet-induced obese animals (Kristensen et al.,
1998; Lambert et al., 1998; Thim et al., 1998; Vrang et al., 1999b;
Edwards et al., 2000; Kask et al., 2000; Larsen et al., 2000; Abbott
et al., 2001; Aja et al., 2001a,b; Bannon et al., 2001; Rohner-
Jeanrenaud et al., 2002; Tachibana et al., 2003;Wortley et al., 2004;
Qing and Chen, 2007; Nakhate et al., 2011, 2013). Furthermore,
the catabolic capacity of CART appeared sufficient to prevent and
attenuate the orexigenic effects of NPY, as i.c.v. and intra-PVN
CART potently suppressed feeding in satiated rats subjected to
NPY-induced hyperphagia (Kristensen et al., 1998; Lambert et al.,
1998; Vrang et al., 1999b; Wang et al., 2000; Rohner-Jeanrenaud
et al., 2002). Similarly, the anorectic potency of CART has also
been demonstrated in a recent study focusing on the interac-
tion between CART and the GABA type A receptor (GABA-A)
active neurosteroid allopregnanolone (ALLO) and the inhibitor
neurosteroid dehydroepiandrosterone sulfate (DHEAs) (Nakhate
et al., 2013). It was shown in rodents that pre-treatment of i.c.v.
CART effectively attenuated subcutaneous ALLO-induced hyper-
phagia and weight gain, as well as potentiating DHEAS-induced
hypophagic and weight reducing effects (Nakhate et al., 2013).
CART administration via the i.c.v. route was also able to elim-
inate the increase in feeding and deleterious weight gain caused
by social isolation in rats (Nakhate et al., 2011), a consequence of
the downregulation of the hypothalamic CART-containing sys-
tem in various hypothalamic feeding-related areas caused by this
condition (Nakhate et al., 2011). In the same study, whilst re-
socialization of the isolation-reared rats restored the food intake,
body weight, and hypothalamic CART-immunoreactivity back
to controls levels, immunoneutralization of endogenous CART
by i.c.v. CART antibody attenuated the restoration, confirming
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the important role of CART in feeding regulation under chronic
psychological stress condition (Nakhate et al., 2011). This is con-
sistent with other studies that used antibodies raised against
different CART segments for blocking central CART signaling,
where all of which were able to neutralize the anorectic prop-
erty of CART and lead to a significant hyperphagic response
(Kristensen et al., 1998; Lambert et al., 1998; Nakhate et al., 2010,
2011). In addition to eliciting an anorectic response, gastroin-
testinal effects including inhibition of gastric acid secretion and
gastric emptying have also been reported as a result from i.c.v.
CART (Okumura et al., 2000; Asakawa et al., 2001; Smedh and
Moran, 2003, 2006; Tebbe et al., 2004). Chronic overproduc-
tion of CART mRNA via viral approaches or continuous infusion
of recombinant CART peptide transferred through i.c.v. cannu-
las into genetically (fa/fa) (Larsen et al., 2000) or diet-induced
(Rohner-Jeanrenaud et al., 2002; Qing and Chen, 2007) obese rats
induces hypophagic effects during fed states and reduced hyper-
phagia following fasting were also observed. Such reduction in
energy intake was accompanied by suppression of body weight
gain mainly due to decrease in leanmass (Larsen et al., 2000; Qing
and Chen, 2007), indicating the potential of CART in the long-
term regulation of food consumption and body mass, under both
normal condition and nutritionally induced obesity.
In conjunction with the characterization of physiological
responses, neuronal activities stimulated by central CART has
been investigated by structural studies for the purpose of identi-
fying brain areas potentially crucial for CART-induced anorectic
effects. Following i.c.v. CART administration, temporal expres-
sion patterns of the immediate early gene c-Fos (Dragunow and
Faull, 1989; VanElzakker et al., 2008), which has been adopted to
depict neuronal firing of actions potentials (Dragunow and Faull,
1989; VanElzakker et al., 2008), were found to concentrate in the
hypothalamic and brainstem structures implicated in the central
regulation of feeding (Vrang et al., 1999b; Zheng et al., 2002). In
the hypothalamus in particular, high density of Fos expression
was located in the PVN and the posterior DMH, while consid-
erable Fos-IR cells were also identified in the Arc and SO. In
the brainstem, Fos-positive cell nuclei were also concentrated in
the PBN and, more importantly, in the NTS, which serves a key
sensory relay nucleus with reciprocal connections with numer-
ous forebrain and brainstem structures (Vrang et al., 1999b).
Such CART-induced Fos activation in the NTS has been indi-
cated independent from possible secondary effects triggered by
chemo-activation at the area postrema (AP) directed to the NTS,
as the chemosensitive neurons in the AP were devoid of Fos-IR
cells (Vrang et al., 1999b). Moderately high Fos expression was
also detected in cerebral nuclei associated with autonomic func-
tions and energy balance (Smith and DeVito, 1984; Vrang et al.,
1999b), including the central nucleus of the amygdala, where
neuronal projections also reciprocally link with the PVN of the
hypothalamus and the PBN and NTS of the hindbrain (Hopkins
and Holstege, 1978; Holstege et al., 1985). The widespread Fos
expression pattern elicited by forebrain i.c.v. CART has been
demonstrated to encompass an anatomical continuum of neu-
ronal activations across the cerebrum, hypothalamus and brain-
stem (Vrang et al., 1999b). The paralleled effects on appetite
inhibition and metabolic regulation are believed to portray an
integrated outcome of the interactions between central CART-
interfered pathways residing primarily within the hypothalamic
and brainstem neurons. For instance, as aforementioned, the
administration of CART combined with other neuromodulatory
such as CCK in mice generated synergistic effects on food intake
and locomotion, while displaying concomitant enhancement in
the number of Fos-positive neurons compared to injecting each
peptide alone (Maletinska et al., 2008; Pirnik et al., 2010). The
additive effect on Fos immunoreactivity was especially notable in
the target areas common to both peptides, namely the hypothala-
mic PVN, DMH, VMH and Arc, as well as NTS at the brainstem
(Maletinska et al., 2008; Pirnik et al., 2010), wherein the CCK-
related satiety signals transmitted to the hindbrain were suggested
to be further regulated by leptin action integrated in the Arc as
well as neuronal signals from both PVN and LHA (Broberger,
2005; Morton et al., 2005; Maletinska et al., 2008).
CART is widely expressed in the brain and particularly con-
centrated in the hypothalamus, suggestive of a diverse range of
functions. While effective, delivery of ligands via the i.c.v. route
is associated with the downside of the simultaneous stimulation
of pathways in various parts of the brain, likely contrasting with
effects attributable to the activation of specific neuronal popu-
lations. One such case are the CART neurons at the Arc, which
respond to and are modulated by leptin signals, leading to the
activation of selective neurons and associated downstream path-
ways (Kristensen et al., 1998; Schwartz et al., 2000). It is therefore
unsurprising that the observed effects of the i.c.v. injection of
substances like CART are not always replicated by targeted deliv-
ery of the same peptide into specific nuclei of the hypothalamus.
Indeed, several studies have shown that targeting CART into indi-
vidual hypothalamic nuclei results in revelation of the orexigenic
effects of CART, leading to increased food intake and body weight
(Abbott et al., 2001; Kong et al., 2003; Smith et al., 2008; Hou
et al., 2010). The strongest orexigenic effects were observed by
injection of CART into the VMH, DMH and Arc, and a much
lesser effect was observed when administered into the PVN, LHA,
anterior hypothalamic area, and SO (Abbott et al., 2001; Kong
et al., 2003; Smith et al., 2008; Hou et al., 2010) (Table 1). Other
effects following Arc and PVN CART delivery such as greater
energy expenditure and thermogenic capacity, as indirectly mea-
sured by the expression and activity of UCP-1 in brown adipose
tissue crucial in thermogenesis, has also been reported (Wang
et al., 2000; Kong et al., 2003) (Table 1).
Despite the dependence of endogenous CART expression on
nutritional states discussed above, energy states of the animals or
dietary options appeared to have little influence over the potency
of CART administration-induced feeding stimulation (Abbott
et al., 2001; Kong et al., 2003; Smith et al., 2008; Hou et al.,
2010). For instance, intra-arcuate delivery of CART resulted in
elevated food intake in rodents under both fasted, food-restricted
and satiated conditions, subjected to the dietary interventions of
either regular chow or HFD (Abbott et al., 2001; Kong et al.,
2003; Hou et al., 2010). Intriguingly, the orexigenic effects of
CART were exhibited in both non-diabetic normal rats as well as
streptozotocin-induced diabetic rats, where the intra-Arc CART-
induced increase in feeding was reproduced under various energy
states and dietary treatments (Hou et al., 2010). Similarly, in rats
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receiving chronic overexpression of recombinant CART virally
delivered into the PVN, higher cumulative food intake and body
weight gain was observed in both groups fed either normal chow
or HFD compared to control groups, with more pronounced
changes in the HFD group (Smith et al., 2008). Underlying
such observations, the appetite-promoting effects of hypothala-
mic intranuclear CART administration may be attributed to a
role of hypothalamic CART in stimulating the release of orexi-
genic neuropeptides locally (Smith et al., 2008; Hou et al., 2010).
This is supported by experiments involving a static incubation
system where an increase in the release of NPY- and AgRP-IR
but not α-MSH-IR was detected in both Arc-containing hypotha-
lamic explants incubated with CART peptide in vitro as well as
in PVN-containing hypothalamic explants isolated from animals
subjected to intra-PVN CART injection (Smith et al., 2008; Hou
et al., 2010). Direct hypothalamic intranuclear CART injection at
specific sites, therefore resulted in feeding behaviors opposite to
the anorectic effects seen for i.c.v. CART.
The discrepancy between the anorexic effects of CART when
injected i.c.v. vs. the predominately orexigenic effects of CART
when delivered into specific hypothalamic nuclei suggests that
CART expression/function in other brain areas may also be
important to the regulation of food intake and energy homeosta-
sis, also suggesting that CART may be involved in both anorex-
igenic and orexigenic circuits in the CNS (Parker and Bloom,
2012). Other potential areas for CART-mediated anorexic effects
include the striatum, which is known to have upregulated CART
expression following acute i.p. administration of psychostimu-
lants (Douglass et al., 1995; Fagergren and Hurd, 1999; Hubert
and Kuhar, 2008), reduced CART mRNA levels following fast-
ing (Kristensen et al., 1998; Adams et al., 1999; Yang and Shieh,
2005), and has been shown to be involved in the mediation of
reward and reinforcement (Koob and Bloom, 1988; Salamone,
1996; Upadhya et al., 2012) as well as the neuronal circuits
controlling feeding behavior (Bakshi and Kelley, 1993; Gilbert
and Cooper, 1995; Pothos et al., 1995; Stratford et al., 1997;
Stratford and Kelley, 1999; Baldo et al., 2002; Yang and Shieh,
2005; Upadhya et al., 2012). Evidence for such a role was gained
from experiments in a strain of CCK-1 receptor-deficient obese
rats, where a significant reduction in CART immunoreactivity
in the Arc was found potentially associated with a diminished
anorectic effect of CART peptide compared to lean controls
(Abraham et al., 2009). Furthermore, intra-accumbal CART pep-
tide injection has been demonstrated to diminish both basal food
consumption and food deprivation-induced feeding (Yang and
Shieh, 2005; Jean et al., 2007), as well as potently attenuating the
orexigenic effects of the GABA-A agonist muscimol (Yang and
Shieh, 2005), albeit some inconsistency across different studies
(Jaworski et al., 2008) (Table 1). The antagonistic effects of the
GABA system and CART at the Acb were also demonstrated in
the neurochemical phenotypes of hypothalamic neurons after the
appetite-inducing microinjection of muscimol into the AcbSh,
which increased Fos expression in orexin neurons at the perifor-
nical area and NPY neurons at the Arc, while inhibiting that in
Arc CART/POMC neurons (Zheng et al., 2003). In a recent study,
subcutaneous injection of the GABA-A active neurosteroid ALLO
significantly reduced CART immunoreactive cells and fibers in
the AcbSh, as well as in other feeding-related hypothalamic nuclei
such as the PVN, Arc and LHA (Nakhate et al., 2013). Direct
CART administration into the Acb performed by an independent
group generated no detectable influence on food reward assessed
by food self-administration, yet triggered inhibitory effects on
cocaine self-administration, an alternative measure of reward and
reinforcement entailing dopaminergic functions (Jaworski et al.,
2008).
The anorexia elicited by intra-accumbal CART was more sus-
tainable in freely fed compared to starved animals, highlighting
the significance of fuel status on CART function in feeding
modulation (Yang and Shieh, 2005). Furthermore, complemen-
tary to the overexpression experiments, RNA-interference has
been employed to investigate the effects of CART depletion
in rodents (Jean et al., 2007; Job and Kuhar, 2012). Tissue-
specific CART knockdown in the Acb via intra-accumbal admin-
istration of short interfering RNA (siRNA) or short hairpin
(shRNA) against CART mRNA induced body weight gain and
hyperphagia in fed mice (Jean et al., 2007; Job and Kuhar,
2012), as well as abolishing the anorectic effects of serotonin
(5-hydroxytryptamine, 5-HT) 4 receptor (5-HT4R) stimulation
as well as 3,4-N-methylenedioxymethamphetamine (MDMA,
ecstasy) treatment in starved mice, further denoting the poten-
tial role of Acb CART in mediating the appetite suppres-
sant properties in models of anorexia nervosa (Jean et al.,
2007).
Despite the body of evidence endorsing the plausibility of
the Acb as a site for CART-directed anorexia, the appetite-
regulating effects produced by intra-accumbal CART likely rep-
resent part of the reward and motivational responses derived
from an interaction between CART and the dopaminergic sys-
tem in the Acb. Multiple lines of evidence have suggested an
inhibitory role of endogenous accumbal CART in addiction-
relevant behaviors, which are speculated to act in concert with
feeding modulation as well as the locomotive effects medi-
ated by the dopaminergic circuits (Kim et al., 2003; Jaworski
et al., 2008; Hubert et al., 2010; Job and Kuhar, 2012; Upadhya
et al., 2012). For instance, substantial innervations have been
described for CART-containing neurons in the ventral pallidum,
a key nucleus harboring accumbal efferents, where CART-IR
terminals were reported to compose symmetric synapses resem-
bling inhibitory GABAergic synapses (Hubert et al., 2010).
Whilst intra-accumbal administration of CART alone produced
no effect on locomotor activity, co-injection with cocaine or
amphetamine into the Acb inhibited the cocaine-like locomo-
tor effects produced by Acb dopamine microinfusions, both
intra-accumbal and intra-pallidal injections of CART peptide
led to reduction in cocaine- and amphetamine-induced loco-
motor activity (Jaworski et al., 2003, 2008; Kim et al., 2003;
Hubert et al., 2010). Correspondingly, CART depletion through
intra-accumbal CART shRNA increased cocaine-mediated loco-
motion (Job and Kuhar, 2012), supporting an antagonistic
property of Acb CART in the functions of cocaine and other
psychostimulants.
The hindbrain, as a region described to convey post-prandial
satiety effects to the hypothalamus, has been considered a
potential candidate site for CART action (Marty et al., 2007;
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Subhedar et al., 2014). Supporting evidence include the mod-
erate CART expression in terms of both transcript levels and
immunoreactivity in caudal brain areas such as the locus
coeruleus, NTS, PBN and the inferior olive (Douglass et al., 1995;
Koylu et al., 1998), accorded with the increased Fos-IR iden-
tified in the NTS and PBN following i.c.v. CART into the LV
(Vrang et al., 1999b). Comparable to i.c.v. injections into the LV
or 3V, hindbrain delivery of CART peptide through the 4th ven-
tricle (4V) led to reduction in food intake and body weight in
both fed and food-deprived rodents, whilst the hypophagic effects
showed no specificity to nutrients from either chow, sucrose or a
nutritionally complete liquid diet (Aja et al., 2001b, 2002; Zheng
et al., 2001, 2002; Skibicka et al., 2009) (Table 1). Importantly,
the extent of feeding inhibition appeared more potent with CART
administered into the 4V compared with LV injections (Zheng
et al., 2001), raising the speculation that the hindbrain may house
the key mediator for the hypophagic effects of i.c.v. CART (Aja
et al., 2001b). Foundation for the idea involved the postulate that
the anorectic effects triggered by forebrain i.c.v. CART indeed
reflected the outcome of CART diffusion into hindbrain sites
via the cerebrospinal fluid (CSF) (Aja et al., 2001b). Surmised
from the CART-IR observed in cell bodies and central terminals
of vagal afferent neurons projecting to the GI tract, a poten-
tial functional role of CART in meal termination and satiety
may effectuate at the level of the brainstem (Broberger et al.,
1999; Zheng et al., 2002). In rat, vagotomy caused considerable
reduction in CART mRNA expression in several CART fibers in
the vagus nerve and viscero-sensory nodose ganglion (Broberger
et al., 1999). To verify such proposition, cerebral aqueduct occlu-
sion was performed with an aqueductal plug to interrupt the
forebrain-hindbrain CSF flow, and CART was injected into the
3V or 4V (Aja et al., 2001b) (Table 1). Interestingly, cerebral aque-
duct blockage markedly attenuated the anorectic effects of 3V
CART, whilst suppression of food intake remained unchanged
when receiving 4V CART injection, signifying the independence
of hindbrain CART in producing anorexia (Aja et al., 2001b).
In contrast, hindbrain processing may be required or responsi-
ble for mediating a hypophagic response following forebrain or
interbrain i.c.v. CART, further reinforcing the role of the brain-
stem inmanifesting CART-driven anorectic effects, as concordant
with the aforementioned higher potency in feeding inhibition
with 4V as opposed to forebrain or interbrain i.c.v. CART (Zheng
et al., 2001). Specifically, on the assumption that the repressed
ingestive behaviors following LV or 3V CART may attribute to
hindbrain CART action, the observations resulted from obtru-
sion of CSF flow could offer a possible explanation for the
opposite feeding effects of orexigenic and anorexigenic natures
induced by direct hypothalamic subnuclei (Wang et al., 2000;
Abbott et al., 2001; Kong et al., 2003; Smith et al., 2008; Hou
et al., 2010) vs. hindbrain ventricular (Aja et al., 2001b, 2002;
Zheng et al., 2001, 2002; Skibicka et al., 2009) CART administra-
tion respectively. Such phenomena promote reevaluation of the
authenticity and proposed mechanisms involved in the hypopha-
gia exhibited after forebrain ventricular CART detailed in other
studies (Kristensen et al., 1998; Lambert et al., 1998; Vrang
et al., 1999b; Larsen et al., 2000; Abbott et al., 2001; Aja et al.,
2001a,b).
FUNCTIONAL IMPLICATIONS OF CART DELETION ON
ENERGY METABOLISM FROM GENETIC INTERVENTIONS
In order to gain further insight into the functional consequences
of reduced or absent CART expression, several knockout mod-
els have been generated and characterized (Asnicar et al., 2001;
Couceyro et al., 2005; Elefteriou et al., 2005; Osei-Hyiaman et al.,
2005; Wierup et al., 2005; Moffett et al., 2006; Steiner et al., 2006)
(Table 2). The phenotypic effects resulting from CART gene tar-
geting approaches have in part shown inconsistency between
studies, however, displayed a general trend in promoting positive
energy balance. This in overall terms is also similar with results
obtained from our novel CART knockout (KO) model, which
was generated from a conditional version that was crossed with
an oozyte-specific Cre line. Collective evidence regarding the role
of CART in energy homeostasis from a few representative stud-
ies conducted by independent research groups (Table 2) as well as
in-house results will be discussed.
In all models investigated, the expected increase in feeding due
to depletion of the anorectic CART peptide was not observed
under standard chow feeding conditions. However, when exposed
to a high caloric diet, lack of CART led to altered feeding behav-
ior and body weight (Asnicar et al., 2001; Couceyro et al., 2005;
Wierup et al., 2005; Moffett et al., 2006). An increase in body
weight has also been shown in CART KO mice fed on regular
chow, although manifestation of such trait appears to require a
longer time frame, where in one study, a statistically significant
increase was absent at 17 weeks of age (Asnicar et al., 2001),
whilst an independent group adopting the identical mouse model
reported notably higher body weight for the knockout mice at
20 weeks (Moffett et al., 2006). In a different CART knockout
mouse line, again altered weight was undetectable prior to 40
weeks of age (Couceyro et al., 2005;Wierup et al., 2005). Similarly,
when fed a high fat diet, a significantly higher food consump-
tion was observed in the CART KO compared to wild-type (WT)
mice (Asnicar et al., 2001), in some but not all studies addressed.
Importantly, despite a lack of consistent alteration in food intake,
all studies reported an elevated body weight gain in CART knock-
out animals regardless of dietary options, with an even more
prominent effect shown with a high caloric diet (Asnicar et al.,
2001; Wierup et al., 2005; Moffett et al., 2006).
Interestingly, fasting-induced food intake experiments in our
novel CART KO model suggest that lack of CART may be ben-
eficial for body weight conservation during starvation. In our
study, chow-fed CART KO animals showed a slightly lower food
consumption compared with WT during a refeeding period fol-
lowing a 24-h fast, yet demonstrated a similar degree and pace
of recovery in body weight, implying that less food might be
required for returning to the pre-fast weight. On the other hand,
the same CART KO mice on HFD experienced a less dramatic
drop in body weight upon fasting, and accordingly showed a
more effective weight regain to baseline during refeeding. Such
improved reactions to food deprivation may be correlated to
the observed difference in growth and possibly attributable to
events in the interaction between CART and an improved stress
response in CART KO mice, consistent with a role of the CART
system in stress and anxiety-like responses (Koylu et al., 2000;
Stanley et al., 2001, 2004; Kong et al., 2003; Larsen et al., 2003;
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Vrang et al., 2003; Dominguez et al., 2004a; Smith et al., 2004;
Gozen et al., 2007; Hunter et al., 2007; Rogge et al., 2008; Nakhate
et al., 2011). For example, i.c.v. CART has been reported to sub-
stantially influence the plasma levels of various stress hormones,
such as adrenocorticotropic hormone and corticosterone (Stanley
et al., 2001). Furthermore, anatomical implication has also been
provided by the expression of CART transcript and peptide at var-
ious levels of the HPA axis as well as other stress-related areas in
the CNS (Douglass et al., 1995; Couceyro et al., 1997; Koylu et al.,
1997, 1998; Elias et al., 1998; Broberger, 1999; Larsen et al., 2003;
Vrang, 2006; Rogge et al., 2008; Nakhate et al., 2011).
Amongst a multitude of potential factors contributing to the
enhanced body weight in CART KO models, the gain in fat mass
has been considered the most important (Asnicar et al., 2001).
This is concordant with results from our novel CART KO model,
where body composition analysis by dual-energy X-ray absorp-
tiometry (DXA) revealed a pronounced increase in adiposity
independent of diet. The gain in whole body fat mass was fur-
ther confirmed by tissue dissection showing significantly elevated
fat masses in all white adipose tissues, including the inguinal, epi-
didymal, mesenteric and retroperitoneal regions. This also sug-
gests an important function of CART in lipid metabolism, where
CART has been linked to inhibition of lipogenesis and stimu-
lation of lipid substrate mobilization and utilization (Rohner-
Jeanrenaud et al., 2002; Wortley et al., 2004; Vasseur et al., 2007;
Banke et al., 2013).
In addition to fat mass, lean mass constitutes another major
determinant of energy homeostasis that directly influences energy
expenditure. As opposed to the increase in fat mass, whole body
lean mass of our CART-deficient mice was distinctly lower com-
pared to WT controls regardless of dietary treatments. Similarly,
the reduction was consistent across both periods of DXA mea-
surements at 10 and 14 weeks of age. Intriguingly, research inves-
tigating the effects of chronic central CART infusion in genetically
normal DIO rats reported a diminished body weight gain primar-
ily due to a loss of lean mass (Larsen et al., 2000; Qing and Chen,
2007), while fat mass was unaffected (Qing and Chen, 2007).
Consistency exists between results from our CART KO model
and previous studies focusing on the metabolic characteriza-
tion of CART knockout mice, where no significant difference in
total energy expenditure or physical activity could be detected
when compared with WT controls regardless of diets (Asnicar
et al., 2001; Moffett et al., 2006), even after the correction of the
potentially confounding effects of lean mass on energy expendi-
ture. However, overexpression studies have provided indications
of both supporting and opposing roles of CART in regulating
energy expenditure (Kong et al., 2003; Qing and Chen, 2007). An
increase in energy expenditure was suggested in rats subject to
chronic overexpression of CART through intra-arcuate targeted
gene transfer, where the animals showed exaggerated weight loss
and a downregulation of endogenous arcuate CART mRNA lev-
els upon fasting and food restriction (Kong et al., 2003). Despite
discordance between various animal studies, evidence exists for
the involvement of CART in the regulation of energy expenditure
and body weight in humans (Challis et al., 2000; del Giudice et al.,
2001; Yamada et al., 2002; Dominguez et al., 2004a; Guerardel
et al., 2005; Yanik et al., 2006; Rigoli et al., 2010). Specifically, a
missense mutation in the pro-CART transcripts was discovered
to co-segregate with a severe obese phenotype and was also asso-
ciated with decreased resting energy expenditure in members of
an Italian family over three generations (del Giudice et al., 2001;
Dominguez et al., 2004a; Yanik et al., 2006).
In spite of a lack of direct indication endorsing a function of
CART in modulating energy expenditure, comparing the respi-
ratory exchange ratio (RER) between CART knockout animals
and WT counterparts may shed light on any potential effects of
CART ablation on energy metabolism through the fuel source
preferences. Although no measurable difference was described in
knockout animals in the respiratory quotient derived fromRER as
reported by previous studies (Asnicar et al., 2001; Moffett et al.,
2006), a notably lower RER has been detected in our new CART
knockout mice. Consistency in the lower RER particularly during
the dark photoperiod was shown across both nutritional statuses,
signifying that fat was preferentially metabolized over carbohy-
drates to supply energy for the body. A possible explanation for
this could be the higher fat content in knockout animals, which
may lead to the predominant fuel source based on the relative
higher availability of fat than carbohydrates. On the other hand,
a suppressed average respiratory quotient was demonstrated in
both normal and DIO rats chronically overexpressing central
CART compared to vehicle-treated controls (Rohner-Jeanrenaud
et al., 2002; Qing and Chen, 2007). The reduction was exaggerated
during the dark phase, under both regular feeding and fasting-
refeeding conditions, indicating a stimulatory role of CART in
promoting lipid oxidation and limiting fat storage, hence inhibit-
ing excessive body fat accrual (Rohner-Jeanrenaud et al., 2002;
Wortley et al., 2004; Qing and Chen, 2007).
Taken together, results from the literature as well as in-house
studies of CART knockout models generally support the property
of CART as a satiety factor and an anorexigenic signal in the brain,
as evident in the elevation in body weight gain attributable mostly
to the increased fat mass consistent across studies, although con-
troversy exists for the corresponding food intake data. As for the
aspect of energy intake, RER was demonstrated to be reduced
both under the conditions of CART overexpression and ablation,
suggesting fat was metabolized as the primary fuel for energy
supply. A possible reason could be that although CART may
intrinsically promote the utilization of fat as the predominant
fuel source for reducing energy intake, the effectiveness of CART
deletion on the disturbance of lipid metabolism hence accumula-
tion of adiposity may have surmounted the simultaneous CART
deficiency-induced enhancement of energy intake, resulting in a
net reduction in RER based on the readily available fat depots.
ROLES OF CART IN HUMAN
As introduced earlier, evolutionary conservation has been
demonstrated for CART in the neuroendocrine system across var-
ious mammalian species in the contexts of isoform structure,
expression distribution pattern as well as functional implications,
including a role of CART in the regulation of energy balance in
human (Hager et al., 1998; Challis et al., 2000; del Giudice et al.,
2001; Yamada et al., 2002; Dominguez et al., 2004a; Guerardel
et al., 2005; Yanik et al., 2006; Rigoli et al., 2010). First, a genome-
wide scan for human obesity-susceptibility loci in obese French
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Caucasian families (Hager et al., 1998) revealed a clear linkage to
the chromosomal locus of 5q13.2 where the human CART gene
is encoded (Table 3). Respectively, the expression of CART tran-
scripts and peptides has been characterized in various hypotha-
lamic areas involved in appetite control (Charnay et al., 1999;
Elias et al., 2001; Menyhért et al., 2007), as well as in the subcuta-
neous and visceral white adipose tissues central to themoderation
of lipid homeostasis (Vasseur et al., 2007; Banke et al., 2013).
Intriguingly, the aforementioned anatomical-functional implica-
tions provided by the expression patterns of CART in the human
infundibular nucleus, which demonstrated colocalization with
the orexigenic NPY/AgRP and segregation from the anorexigenic
POMC neurons, had rendered a primary anorectic role of CART
appealable (Menyhért et al., 2007).
In human, alterations in CART have been associated with
reduced metabolic rate, hyperphagia, obesity and elevated inci-
dence of type II diabetes (Banke et al., 2013) (Table 3). For
example, a Leu34Phe missense mutation in human proCART was
discovered in obesemembers of an Italian family across three gen-
erations to affect post-translational processing, which coincided
with CART peptide deficiency in the sera and reduced resting
energy expenditure, ultimately leading to hyperphagia and severe
early-onset obesity (del Giudice et al., 2001; Dominguez et al.,
2004a; Yanik et al., 2006). In brief, the mutation was identified
to neighbor a cluster of basic amino acids, hence presupposed
to influence the specific processing of the proCART (1–89) in
generating the biologically active CART I (42–89) and CART
II (49–89) peptides (Kuhar and Yoho, 1999; Thim et al., 1999;
del Giudice et al., 2001; Dominguez et al., 2004a). To simulate
cellular effects of the mutation, subsequent investigations trans-
fected human CART cDNA constructs representing either the
wild-type or the mutant into corticotropic AtT-20 cells, a mouse
pituitary-derived cell line often used for studying peptide pro-
cessing and, more importantly, is known to express and process
CART peptides (Dominguez et al., 2004a). Notably, in addition to
reduced CART peptide levels in cells transfected with the mutated
cDNA compared with controls, expression of the mutated pro-
CART was also described to be mis-sorted, poorly processed
and secreted, thus disarranging the cellular distribution of CART
as a whole (Dominguez et al., 2004a). Other than discoveries
that addressed the potentially crucial role of protein biosynthe-
sis in the development of obesity, the majority of the studies
directed at the association between CART and obesity focused on
polymorphisms in CART within populations.
Polymorphism studies in the CART gene conducted world-
wide have established substantial linkage between a few specific
single nucleotide polymorphisms (SNPs) to obesity (del Giudice
et al., 2001; Yamada et al., 2002; Guerardel et al., 2005; Rigoli et al.,
2010) (Table 3). For instance, a family-based association study of
133 Italian trios has identified significantly higher allele frequen-
cies of the 1475A>G SNP in the CART gene in overweight and
obese children compared to non-obese unrelated controls consist-
ing of both adults and children, while preferential transmission
of the allele to overweight or obese children from heterozygous
parents was predicted (Rigoli et al., 2010). In another Caucasian
population, 292 French morbidly obese subjects were recruited
for sequence variability screen in the CART gene, where a few
SNPs residing in the promoter region, with SNP-3608T>C in
particular, were suggested by haplotype analysis to prominently
contribute to the genetic risk for obesity (Guerardel et al., 2005).
The proposed association was further strengthened by the high
prevalence of the specific allele in an expanded genotyping study,
with additional populations of European Caucasian origin com-
prising 619 moderately obese French subjects and 385 morbidly
obese Swiss subjects (Guerardel et al., 2005). Extended on the
genetic studies, plausible functional effects of the SNP were also
investigated by electrophoretic mobility shift assays in cellular sys-
tem, where modulation of nuclear protein binding affinity was
demonstrated to potentially correlate with the obesity phenotype
(Guerardel et al., 2005). Besides Caucasians, a sequencing study in
528 Japanese subjects revealed a high level of polymorphisms in
the 5′-flanking region of theCART gene housing the putative pro-
moter region, wherein specific polymorphic sites or variants in
linkage disequilibriumwith each other were identified to associate
with genetic predisposition to obesity (Yamada et al., 2002).
As mentioned, CART has recently been defined as a com-
ponent of adipocytes involved in lipid substrate utilization in
both human and rodents (Banke et al., 2013). Investigation in
a large Caucasian population of approximately 1000 subjects in
the United Kingdom identified two common polymorphisms in
the 3′-untranslated region ofCART, that were implicated to inter-
fere with fat distribution and contribute to dyslipidaemia (Challis
et al., 2000; Rogge et al., 2008) (Table 3). Despite a lack of corre-
lation or consistent association with obesity through systematic
mutational analysis (Lambert et al., 1998; Challis et al., 2000;
Okumura et al., 2000; Rogge et al., 2008), a particular genetic
variant 1475A>G among the polymorphisms was illustrated to
significantly affect waist-to-hip ratio as well as the levels of plasma
insulin and triglycerides (Challis et al., 2000), suggesting a puta-
tive pivotal role of CART in glucose- and lipid-homeostasis.
Consolidation of the proposition has been illustrated in subse-
quent haplotypic study in a general population of 840 subjects
from northern France (Vasseur et al., 2007), a continuum from
the former French project on CART promoter SNPs (Guerardel
et al., 2005), where three of the previously identified SNPs were
described to affect plasma low-density lipoprotein-cholesterol
level and consequently associated with cholesterol metabolism
and atherogenicity (Guerardel et al., 2005; Vasseur et al., 2007).
Specifically, the functional SNP-3808C>T was of particular inter-
est, as plasma lipid profile traits protective against atherogenesis
were displayed in cases bearing the allele, exemplifying the clin-
ical potentials of CART in lipid metabolism and atherogenesis
(Vasseur et al., 2007; Banke et al., 2013).
Taken together, human studies based principally on genetic
polymorphisms have provided evidence promoting a role of
CART in body weight regulation in humans. Altered CART
expression has generally been associated with an elevated genetic
predisposition to overweight and obesity, indirectly substantiat-
ing the anorexigenic nature of the peptide, although results from
the literature show both anorexigenic and orexigenic properties of
CART in animal studies. It is also noteworthy to address the plau-
sible challenges imposed on the translatability of results obtained
from animal models to the human system, considering the dis-
cernible difference in the anatomy of central CART-containing
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neurons between the two, as discussed above. Furthermore,
although overall support has been gained for the hypothesis
that inherited variations in CART could influence the develop-
ment of obesity, such genetic linkage was absent for some other
sequence variants detected within the gene, where the polymor-
phisms have been speculated as insufficient to disturb the peptide
structure or create topological and conformational changes in
the protein that would ultimately affect the functional activity
of the peptide (Echwald et al., 1999; Walder et al., 2000; Rogge
et al., 2008). Indeed, recent studies conducting an alanine scan
for assessing the importance of the structure-activity relationship
of CART demonstrated the dependence of anorexigenic potency
on individual disulfide bridges in the peptide (Maixnerova et al.,
2007; Maletinska et al., 2007; Blechova et al., 2013). To eluci-
date the contribution of specific disulfide bridges to maintaining
the stability and biological function of CART, analogs with only
one or two among the three disulfide bridges in the intact pep-
tide were synthesized, with which binding activities as well as
metabolic effects were measured in both cell and animal sys-
tems (Maixnerova et al., 2007). Intriguingly, results from binding
experiments in PC12 rat pheochromocytoma cells (Maixnerova
et al., 2007; Maletinska et al., 2007; Lin et al., 2011) indicated
that the preservation of two particular disulfide bridges as well
as the full-length peptide was imperative for biological activity,
where high affinity of the analog to PC12 cells in both states of
native phenotype and differentiated into neurons was measured
(Blechova et al., 2013). In mice subjected to i.c.v. administra-
tion of the same analog, strong and long-lasting anorexigenic
potency was exhibited during food consumption and behavioral
tests, further purporting that one particular disulfide bridge could
be omitted without a loss of bioactive function (Blechova et al.,
2013).
In summary, the familial nature of obesity is well-established
to be interrelated with a prominent genetic component. The
CART system has been evident to constitute a dominant player in
feeding control, body weight regulation and energy metabolism,
hence a promising candidate for the development of anti-obesity
therapeutics. Respectively, population genetics have revealed the
potential contributions of polymorphisms in the CART gene to
abnormalities in feeding and body weight control, where effects
on interactions between the transcription factors and regulatory
elements binding to the polymorphic sites may exert phenotypic
influence. However, elucidating the mechanisms of CART action
as well as investigating and replicating the fine genetic map-
ping in further populations will be essential for unraveling the
authentic role of CART in energy homeostasis and understanding
obesity.
CONCLUSION
In conclusion, the widely adopted role of CART in the regula-
tion of energy homeostasis has been summarized in this review
from the perspectives of genetic and transcriptional associa-
tions, anatomical-functional correlation, pharmacological and
genetic intervention studies in animal models, as well as impli-
cations from sequence variability in human. Nevertheless, the
lack of a known CART receptor(s) and specific antagonists, con-
tinues to constitute the major challenge in understanding the
underlying mechanisms by which CART exerts effects on feeding
and neuroendocrine regulation.
The physiological importance of CART is endorsed by the evo-
lutionarily conserved expression patterns in the brain as well as
the periphery at regions associated with energy balance, inferring
structural hence functional conservation in glucose sensing, lipo-
genesis regulation and ultimately the control of feeding behavior.
The resultant integrated outcome on metabolic modulation also
represents the neuronal crosstalk involving similar neuromodula-
tory peptides between central CART-interfered pathways residing
at the hypothalamic and brainstem neurons as well as via the
hypothalamic-pituitary-adrenal axis. In comparison with CART
in the brain, functional roles of peripheral CART are less estab-
lished, with indeterminate modes of action speculated to entail
either a local independent response, or synergistic effects with
central CART.
Overexpression of central CART through i.c.v. injections at
either the forebrain (LV), interbrain (3V) or hindbrain (4V)
areas has conformed to an anorexigenic role of CART, while the
appetite-promoting effects of CART administered into specific
neuronal targets may be attributed to a role of hypothalamic
CART in stimulating the local release of orexigenic neuropep-
tides in a hypothalamic nucleus-specific manner. The discrepancy
in anorexigenic and orexigenic circuitry highlights the major
pitfall of non-specific widespread effects associated with i.c.v.
ligand delivery, and was recognized through the efforts to iden-
tify potential sites for CART action following the analysis of Fos
expression pattern representative of i.c.v. CART-induced neu-
ronal activities. Candidate sites that may house the key mediator
for the hypophagic effects of i.c.v. CART primarily reside in var-
ious feeding-related areas, including major hypothalamic nuclei,
specific brainstem structures, and the Acb of the cerebral stria-
tum. The appetite-inhibiting and -promoting effects produced
by intra-accumbal CART and CART siRNA respectively reflect a
concerted response from the CART-dopaminergic system inter-
action within the Acb, hence the observed feeding modulation
and locomotive effects were likely perplexed by the inherent
reward and motivation pathway. Several hindbrain areas are of
particular interest as alternative brain regions for CART-induced
anorexic effects, owing to the well-described role of the hindbrain
in conveying post-prandial satiety effects to the hypothalamus,
consonant with the indicated relation between CART and vagally-
mediated gastrointestinal satiety.
In parallel with overexpression approaches, independent
research groups have adopted genetic ablation to generate several
germline CART knockout murine models, to determine effects of
CART depletion on feeding behavior and metabolism. General
consistency has been demonstrated between results from the lit-
erature and in-house data from our novel CART KO model,
supporting CART as a satiety factor. Collectively, the pheno-
typic effects of CART deficiency from birth, although inconsistent
across studies, display promotion toward positive energy bal-
ance. Extended findings stemming from our novel KO model
also denote that CART deficiency may confer an advantage in
body weight conservation during starvation, potentially associ-
ated with an improved stress response attributable to an altered
anxiety-related cascade involving the CART system.
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Both gene knockout and overexpression studies of CART have
consolidated the stimulatory role of CART in promoting lipid oxi-
dation and inhibiting fat accrual. As discussed above, despite the
widely documented anorectic evidence of CART, possibility of
an orexigenic role is indisputable. Under certain circumstances,
such postulation may provide explanation for the inconsistent or
lack of marked phenotypes in terms of energy balance observed
in germline CART knockout animals, as well as conditional,
developmental stage, or whole brain CART knockout models.
Nevertheless, temporal or tissue-specific genetic ablation serves
an invaluable means tominimize common pitfalls associated with
a germline knockout strategy, such as any secondary effects or
compensatory mechanisms during development.
In human, the expression of CART transcripts and peptides
has been characterized in various hypothalamic areas involved
in appetite control and lipid homeostasis. From the perspective
of population genetics, genome-wide study of human obesity-
susceptibility loci revealed linkage to a locus harboring the human
CART gene, whereas mutation profiling has associated alterations
in CART with reduced metabolic rate and resting energy expen-
diture, hyperphagia, obesity and elevated incidence of type II
diabetes. Intriguingly, whilst a role of CART in regulating energy
expenditure remains equivocal in overexpression studies and con-
sidered discordant in gene deletion approach in animal models,
mutation screening in humans has consolidated the involvement
of CART in the modulation of energy expenditure, body weight
and dyslipidaemia.
To elucidate the underlying cellular mechanisms, functional
effects of mutations and polymorphisms that were linked to the
development of obesity were investigated. The sequence alter-
ations of interests were described to potentially interfere with
the post-translational processing of CART, leading to defective
protein biosynthesis and deranged cellular distribution of the
peptide, while modulation in the nuclear protein binding affin-
ity was also reported to attenuate biological activity. Despite the
plausible challenges imposed on the translatability of principal
observations from animal models to the less well-documented
human system, aberrations in CART have been demonstrated in
human studies to promote positive energy balance, endorsing a
primary anorectic role of CART.
In sum, the CART system remains a dominant player in
the regulation of feeding, body weight and energy metabolism,
hence a promising candidate for the development of anti-obesity
therapeutics. However, elucidating the underlying mechanisms
of CART action, developing relevant pharmacological tools and
understanding the nature of the endogenous CART receptor(s),
remains crucial in unraveling the functional role of CART in
energy homeostasis and obesity.
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